Group One Trading L.P. Sells 1,600 Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC)

Group One Trading L.P. lessened its position in Alphatec Holdings, Inc. (NASDAQ:ATEC – Get Rating) by 30.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,701 shares of the medical technology company’s stock after selling 1,600 shares during the quarter. Group One Trading L.P.’s holdings in Alphatec were worth $32,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in ATEC. Cerity Partners LLC increased its position in Alphatec by 0.6% during the 2nd quarter. Cerity Partners LLC now owns 1,595,229 shares of the medical technology company’s stock valued at $10,433,000 after purchasing an additional 10,221 shares during the period. Walleye Trading LLC increased its position in Alphatec by 102.9% during the 2nd quarter. Walleye Trading LLC now owns 21,942 shares of the medical technology company’s stock valued at $144,000 after purchasing an additional 11,126 shares during the period. NewEdge Advisors LLC increased its position in Alphatec by 17.3% during the 2nd quarter. NewEdge Advisors LLC now owns 93,001 shares of the medical technology company’s stock valued at $608,000 after purchasing an additional 13,744 shares during the period. Jump Financial LLC increased its position in Alphatec by 8.9% during the 3rd quarter. Jump Financial LLC now owns 76,900 shares of the medical technology company’s stock valued at $672,000 after purchasing an additional 6,300 shares during the period. Finally, Penn Capital Management Company LLC increased its position in Alphatec by 37.1% during the 2nd quarter. Penn Capital Management Company LLC now owns 1,633,034 shares of the medical technology company’s stock valued at $10,680,000 after purchasing an additional 442,021 shares during the period. Institutional investors own 48.59% of the company’s stock.

Alphatec Stock Up 0.3 %

ATEC stock opened at $14.85 on Tuesday. The firm has a market cap of $1.56 billion, a PE ratio of -9.64 and a beta of 1.27. The company has a debt-to-equity ratio of 29.74, a quick ratio of 1.33 and a current ratio of 2.14. The firm’s fifty day moving average is $12.97 and its 200 day moving average is $10.57. Alphatec Holdings, Inc. has a one year low of $5.73 and a one year high of $14.99.

Wall Street Analyst Weigh In

A number of research analysts have commented on ATEC shares. Lake Street Capital raised their target price on shares of Alphatec from $16.50 to $20.00 and gave the company a “buy” rating in a research report on Thursday, January 12th. Needham & Company LLC lifted their price objective on shares of Alphatec from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Friday, November 4th. Finally, Morgan Stanley boosted their price objective on shares of Alphatec from $15.00 to $17.00 and gave the stock an “overweight” rating in a research note on Friday, January 6th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $15.64.

Insider Activity at Alphatec

In related news, SVP Scott Lish sold 9,570 shares of the firm’s stock in a transaction on Tuesday, February 21st. The shares were sold at an average price of $14.02, for a total transaction of $134,171.40. Following the sale, the senior vice president now owns 465,534 shares in the company, valued at $6,526,786.68. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, SVP Scott Lish sold 9,570 shares of the firm’s stock in a transaction on Tuesday, February 21st. The shares were sold at an average price of $14.02, for a total transaction of $134,171.40. Following the sale, the senior vice president now owns 465,534 shares in the company, valued at $6,526,786.68. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP David Sponsel sold 10,000 shares of the firm’s stock in a transaction on Monday, December 5th. The shares were sold at an average price of $9.88, for a total transaction of $98,800.00. Following the sale, the executive vice president now owns 556,983 shares in the company, valued at approximately $5,502,992.04. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 400,854 shares of company stock worth $5,263,315. 33.93% of the stock is owned by company insiders.

Alphatec Profile

(Get Rating)

Alphatec Holdings, Inc engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings.